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The activation of cellular senescence throughout the lifespan
promotes tumor suppression, whereas the persistence of senescent
cells contributes to aspects of aging. This theory has been limited,
however, by an inability to identify and isolate individual senescent
cells within an intact organism. Toward that end, we generated a
murine reporter strain by “knocking-in” a fluorochrome, tandem-
dimer Tomato (tdTom), into exon 1α of the p16INK4a locus. We used
this allele (p16tdTom) for the enumeration, isolation, and character-
ization of individual p16INK4a-expressing cells (tdTom+). The half-life
of the knocked-in transcript was shorter than that of the endoge-
nous p16INK4a mRNA, and therefore reporter expression better cor-
related with p16INK4a promoter activation than p16INK4a transcript
abundance. The frequency of tdTom+ cells increased with serial
passage in culturedmurine embryo fibroblasts from p16tdTom/+ mice.
In adult mice, tdTom+ cells could be readily detected at low fre-
quency in many tissues, and the frequency of these cells increased
with aging. Using an in vivo model of peritoneal inflammation,
we compared the phenotype of cells with or without activation of
p16INK4a and found that tdTom+ macrophages exhibited some fea-
tures of senescence, including reduced proliferation, senescence-
associated β-galactosidase (SA-β-gal) activation, and increased mRNA
expression of a subset of transcripts encoding factors involved in
SA-secretory phenotype (SASP). These results indicate that cells har-
boring activation of the p16INK4a promoter accumulate with aging
and inflammation in vivo, and display characteristics of senescence.
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Cellular senescence refers to a specific form of highly durablecell cycle arrest of previously proliferation-competent cells
that is resistant to mitogenic stimulation and accompanied by
persistent DNA damage response. Senescence is an important
tumor-suppressor mechanism, and is believed to contribute to or-
ganismal aging (1, 2). A senescence response is triggered by a va-
riety of genotoxic stresses, including shortened telomeres, exposure
to DNA damaging agents, and oncogenic insult (1, 3). While se-
nescence is primarily characterized in replication-competent cells,
recent studies have suggested that largely postmitotic cell types can
also initiate a senescence program (4, 5). In addition to growth
arrest, senescence is variably associated with the expression of
cyclin-dependent kinase (CDK) inhibitors (especially p16INK4a),
senescence-associated β-galactosidase (SA-β-gal) activity, and the
elaboration of cytokines that comprise the SA-secretory phenotype
(SASP) (3, 6). Given the prominence of senescence in cancer and
aging, there has been great interest in the identification and
characterization of senescent cells in an intact adult organism.
Although senescent cells are well-characterized in culture,
identifying senescent cells in vivo has been challenging (6). The
inability to reliably identify senescent cells in an intact organism
has impaired the study of their precise role in tumor suppression
and physiological aging. To date, activation of p16INK4a expression
has proven to be one of the most useful in vivo markers of se-
nescence. As a cell cycle regulator, p16INK4a limits G1 to S-phase
progression of the cell cycle through inhibition of the CDK4 and
CDK6 (CDK4/6) kinases (7). Moreover, the expression of p16INK4a
is highly dynamic, being largely undetectable in healthy young
tissues, but rising sharply in many tissues with aging (8, 9) or after
certain sorts of tissue injury (10–12). Murine studies suggest that
accumulation of p16INK4a leads to an age-related loss of replicative
capacity in select tissues, thereby causing some phenotypic as-
pects of aging (13–16). The clearance of p16INK4a-expressing cells
attenuates age-associated phenotypes and improves the healthy
lifespan of progeroid and physiologically aged mice (17, 18). These
murine results are underscored by a remarkable string of associ-
ations of the CDKN2a/b locus (encoding the p16INK4a, ARF, and
p15INK4b transcripts) with human age-related phenotypes by
genome-wide association studies (19, 20).
In prior work, activation of the p16INK4a promoter has been
used to suggest senescence in vivo. Our laboratory and others
have placed reporter genes [e.g., luciferase (LUC)] under the
control of the p16INK4a promoter by either transgenic (10, 17, 21,
22) or knockin approaches (23). These reporter alleles have been
employed to demonstrate that the p16INK4a promoter activity
increases during wounding, inflammation, tumorigenesis, or ag-
ing in vivo in tissues. While valuable for studies at the tissue or
organ level, these alleles have been limited in their ability to
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detect and isolate individual cells with strong activation of the
p16INK4a promoter in vivo. To study individual p16INK4a-activated
cells, we have generated a fluorescence-based reporter allele with
tandem-dimer Tomato (tdTom) knocked into the endogenous
p16INK4a locus. This allele enables the identification and isolation
of p16INK4a-activated cells (tdTom+) at the single-cell level from
cultured cells and in vivo. Using this allele, we quantified tdTom+
cells in several tissues with aging or in the setting of inflammation,
and isolated these cells for characterization in terms of function
and gene expression.
Results
Generation and Characterization of the p16tdTom Allele. To study in-
dividual p16INK4a-expressing cells from in vivo sources, we knocked
an ORF encoding a fluorescent reporter protein (tdTom) into the
endogenous first exon (exon 1α) of p16INK4a through homologous
recombination (Fig. 1A). The targeted allele (p16tdTom) was de-
signed to be null for p16INK4a expression, yet with unperturbed ex-
pression of the Arf transcript, as well as retention of cis-regulatory
elements around the Cdkn2a (or Ink4a/Arf) locus. A stop codon and
poly-A signal were included at the end of the knocked-in tdTom
ORF, and therefore the targeted mRNA would not be expected
to produce a message that splices to exon 2. Importantly, a flippase
recognition site (FRT)-flanked neomycin selection cassette under
the regulation of a strong PGK promoter was knocked into the
first intron to allow for ES cell selection (Fig. 1A). Correct homol-
ogous targeting was verified by PCR, sequencing, and Southern blot
(SI Appendix, Fig. S1 A and B).
Prior efforts in our laboratory failed to produce a usable single-
cell reporter allele through similar approaches. Despite correct
knockin targeting, alleles featuring p16INK4a-GFP or p16INK4a-CRE
recombinase (which could be used to activate Lox-STOP-Lox
GFP alleles) were abandoned due to low expression of the knocked-
in ORF. Therefore, to maximize reporter expression with the
tdTom knockin allele, we did two additional things. First, we
chose to knock in tdTom, which is six times brighter than GFP
but without the predisposition to aggregation and toxicity of
other red fluorescent alleles (24). Second, given prior work showing
that a retained neomycin cassette can act as a local enhancer to
augment reporter expression without compromising tissue reporter
fidelity (25, 26), we elected to characterize the p16tdTom allele in
cells with both a retained neomycin selection cassette and after
flippase (FLP)-mediated excision.
We assessed the allele function in cultured murine embryonic
fibroblasts (MEFs) heterozygous for the tdTom knockin (p16tdTom/+).
In line with prior results (23, 27, 28), p16tdTom/+ and WT MEFs have
comparable growth characteristics at early passage (SI Appendix,
Fig. S1C). As expected (29, 30), serial passage induced increasing
expression of endogenous p16INK4a mRNA produced from the
WT locus and tdTom transcript from the p16tdTom allele (Fig. 1B).
The frequency of tdTom+ cells identified by flow cytometry also
increased with passage (Fig. 1C). While the frequency of tdTom+
MEFs increased with passage in cells derived from mice retaining
(“Neo-in”) or without (“Neo-out”) the neomycin cassette, the
frequency of tdTom+ cells in Neo-in cultures was an order-of-
magnitude higher. For example, we show a comparison of MEFs at
passage 7 (∼25 d in culture) where 1.9% of Neo-out cells and
19.6% of Neo-in cells were tdTom+ (SI Appendix, Fig. S2A). To
determine which allele was more faithful to endogenous p16INK4a
expression, we measured tdTom and p16INK4a transcript levels in
heterozygous cells (Neo-in/WT or Neo-out/WT) by qRT-PCR. As
was the case for tdTom protein, the tdTom mRNA increased
with passage in cells derived from both Neo-in or Neo-out mice,
but mRNA expression was more dynamic with passage in Neo-in
cells (SI Appendix, Fig. S2B). Correspondingly, tdTom mRNA
expression in Neo-in/WT cells strongly correlated with p16INK4a
expression when measured in multiple independent MEF lines






Fig. 1. Design and validation of the p16tdTom allele. (A) Schematic of the p16tdTom knockin targeting strategy. Frt, flippase recognition site; Neo, neomycin
resistance gene. (B–D) Induction of p16INK4a and tdTom expression in p16tdTom/+ MEFs over serial passage. P3, passage 3; P7, passage 7; P10, passage 10. mRNA
expression of p16INK4a and tdTom by qRT-PCR. Fold-increase was calculated with respect to the mRNA levels at P3. Data shown correspond to three biological
replicates. Error bars represent SEM (B). Representative flow cytometric (FACS) analysis of MEFs at indicated passage number (C). Correlation of p16INK4a and
p16tdTom mRNA expression shown in the normalized threshold cycle (ct) value. Passage number is presented by different colors. Linear regression was used to
calculate the coefficient of determination (R2) (D). (E and F) Linear correlations between p16INK4a, p16tdTom, and Glb1 mRNA expression on single-cell levels.
Expression levels are shown in the comparative threshold cycle (ct) values. Each dot represents a single cell.
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tdTom expression in Neo-out cells was more frequently below the
lower limit of detection, and therefore correlated less well with
endogenous p16INK4a mRNA (SI Appendix, Fig. S2C) (R2 =
0.73). Given the higher fidelity and stronger signal using the
Neo-in allele, we elected to pursue all subsequent experiments
using this version, and henceforth “p16tdTom” will designate the Neo-in
allele. To test the functionality of this single-cell reporter, we
assessed the expression of tdTom and p16INK4a on the single-cell
level. By single-cell qRT-PCR, we noted a significant associa-
tion between tdTom and p16INK4a expression (Fig. 1E) (R2 =
0.32; P = 0.0002). Additionally, we found tdTom levels signif-
icantly correlated with β-galactosidase (Glb1) levels as well
(Fig. 1F) (R2 = 0.12; P = 0.0346).
The p16tdTom Allele Reports Promoter Activation. Although expres-
sion of the reporter transcript strongly correlated with that of the
WT allele (Fig. 1 D and E), the absolute level of tdTom was
lower than that of the native p16INK4a transcript in cultured
p16tdTom/+ MEFs (SI Appendix, Fig. S3A). This pattern was also
noted with the previously published p16LUC allele (23). To ex-
plain this recurrent finding that expression of the endogenous
allele was reproducibly 5- to 10-fold higher than the knocked-in
allele in heterozygous cells, we considered the possibility that
mRNA stability differs between the various knocked-in ORFs
versus the endogenous p16INK4a transcript. Hara et al. (31) re-
ported that both the p16INK4a and ARF mRNAs exhibit a re-
markable stability, with half-lives that are >24 h, a finding that
our group has confirmed in human and murine cells (32). Of
note, >95% of linear, coding mRNAs exhibit a half-life of less
than 12 h (33), indicating that this is an unusual feature of the
INK4a/ARF transcripts. We used actinomycin D (ActD)
treatment followed by qRT-PCR quantification to determine
the mRNA half-life of the endogenous p16INK4a and Arf
mRNAs, as well as the tdTom mRNA in p16tdTom/+ MEFs (SI
Appendix, Fig. S3B). As expected, the p16INK4a and Arf tran-
scripts showed little change for up to 24 h after ActD treat-
ment, whereas the tdTom transcript exhibited a half-life of
∼12 h (SI Appendix, Fig. S3B). The decreased stability of these
knocked-in transcripts occurs despite the inclusion of a 3′
poly-A signal derived from SV40 that augments transcript
stability in other systems (34). These observations indicate that
the lower expression of transcripts knocked into exon 1α of the
Cdkn2a locus, and commensurately weak expression of re-
porter proteins, reflects the fact that the knocked-in transcripts
do not recapitulate the extraordinary stability of the endoge-
nous p16INK4a mRNA.
We next examined the levels of p16INK4a mRNA in p16tdTom/+
cells that were either tdTom+ or tdTom−. We sorted MEF cul-
tures using FACS based on tdTom expression (Fig. 2A) and
measured p16INK4a mRNA levels in each fraction (Fig. 2B). We
noted a moderate enrichment of p16INK4a mRNA in tdTom+
MEFs (∼fivefold), but p16INK4a mRNA was readily detectable in
tdTom− fractions at all passages tested. Given the observed
differences in p16INK4a vs. tdTom transcript half-life, we analyzed
their relative expressions in MEF cultures for up to 14 d post-
sorting. When analyzed in this way, we noted that expression of
tdTom protein and p16INK4a mRNA began to diverge with long-
term culture. At day 1 postsort, virtually all cells in the tdTom+
fraction remained tdTom+, but this fraction steadily declined
with culture, such that at 14 d post-FACS, >30% of formerly
tdTom+ cells had reverted to a tdTom− state (Fig. 2 C and D).
We believe this largely reflects reversion of tdTom+ cells as
opposed to overgrowth of the culture by tdTom− cells for two
reasons. First, the proliferation rate in the tdTom+ cultures
remained low for 2 wk after sorting, which would not be consistent
with an expansion of proliferating tdTom− cells. Moreover, during
the period of culture, tdTom+ MEFs exhibited a significant further
accumulation of p16INK4a transcript (Fig. 2E), which would not be
expected with expansion of tdTom− cells. Of note, levels of tdTom
mRNA in cells sorted as tdTom+ on day 1 were little changed over
14 d of culture (Fig. 2E). These results suggest that while tdTom
protein expression has “peaked” at the time of FACS and then
decreases in some tdTom+ cells, levels of p16INK4a continues to
sharply rise in the same cells for weeks after sorting. We believe
these results have significant implications as to the interpreta-
tion of what the p16tdTom reporter allele actually reports. Spe-
cifically, these results suggest that tdTom positivity is a better
proxy for high-level activation of the p16INK4a promoter rather
than total abundance of the p16INK4a transcript. This in turn
indicates that some cells with formerly strong activation of the
p16INK4a promoter could appear tdTom− a few weeks later (as in
Fig. 2C), despite high-level expression of the p16INK4a transcript
(and presumably protein).
Characterization of p16INK4a Transcriptionally Active Cells in Vitro.
Using the p16tdTom allele, we next turned to the question of
the functional properties of cultured cells featuring high-level
p16INK4a promoter activation. FACS-isolated tdTom+ MEFs
showed lower rates of growth (Fig. 3A) and decreased in-
corporation of a thymidine analog, 5-ethyl-2′-deoxyuridine (EdU)
(Fig. 3B) compared with tdTom− cells, and exhibited higher ac-
tivity of SA-β-gal in culture (Fig. 3 C and D). We performed an
unbiased analysis of RNA expression by next-generation se-
quencing (RNA-seq) in tdTom+ vs. tdTom− cells with or without
serum starvation (0.1% FBS for 48 h). While serum starvation
induced a decline in the expression of mRNAs associated with
proliferation (cell cycle, E2F) as expected, an even greater re-
duction in the expression of proliferative mRNAs was noted in
tdTom+ compared with tdTom− cells (SI Appendix, Fig. S4A).
Gene set enrichment analysis (GSEA) of tdTom+ vs. tdTom−
MEFs also demonstrated enrichment of signatures associated with
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Fig. 2. Promoter activity of the p16tdTom allele. (A) Representative FACS
analysis of tdTom− and tdTom+ populations at day 1 postsort. (B) mRNA ex-
pression of p16INK4a by qRT-PCR. Fold-difference was calculated with respect to
the mRNA levels in tdTom− MEFs (**P < 0.01). (C) Representative FACS
analysis of the cultured tdTom+ MEFs at indicated time points after cell
sorting. (D) Frequency of tdTom+ cells in the tdTom+ cultures at indicated
time points after cell sorting. (E ) Absolute copy number of p16INK4a and
tdTom in cultured tdTom+ MEFs by qRT-PCR at indicated time points after
cell sorting. Throughout, error bars represent SEM.








cells consistent with their increased rates of proliferation. Addi-
tionally, GSEA demonstrated differential expression of many
signatures associated with developing tissue lineages: for example,
neural, cardiac, cutaneous, and hematopoietic (e.g., synaptic sig-
naling and leukocyte development shown in SI Appendix, Fig.
S4B). Given that MEF cultures are derived from disaggregated
whole murine embryos, we believe this finding reflects an in-
creased propensity to activate p16INK4a expression in certain tissue
types (e.g., brain, heart, and skin), but not others (e.g., leukocytes).
For the RNA-seq analyses, we developed a list of SASP transcripts
compiled from several sources studying senescence in a variety of
human or murine cell types (35–38) (SI Appendix, Table S1).
Using this list, there was no association of SASP transcript ex-
pression with either serum starvation or tdTom expression in
MEFs (SI Appendix, Fig. S4A). These findings could indicate that
p16INK4a-activated, hyporeplicative MEF cultures expressing SA-
β-gal are not “truly” senescent (although cells in such cultures
have long been considered so in our field), or indicate that a
transcriptional signature of the SASP is difficult to discern in a
heterogeneous culture of mixed embryo tissues.
Enumeration of p16INK4a-Activated Cells in Vivo. Although evidence
suggests that the in vivo accumulation of senescent cells con-
tributes to age-associated tissue dysfunction, the frequency of
senescent cells within different aged tissues is unclear. To ad-
dress this issue, we examined the percentage of tdTom+ cells
from tissues harvested from young (8–12 wk) or old (100–
120 wk) p16tdTom/+ mice. As p16INK4a mRNA is readily detected
in murine or human peripheral blood T cells and increases with
aging (9, 16), we examined the frequency of tdTom+ cells in
peripheral blood CD3+ (T cells), B220+, or Mac-1+ (myeloid
cells) populations every 6 mo through phlebotomy. In these
compartments, there was only a minimal increase in the fre-
quency of tdTom+ cells with aging (Fig. 4A). Of note, a subset of
mice (n = 6) displayed a transient, high-level increase in the
frequency of tdTom+ cells in peripheral blood at the time of
routine phlebotomy (SI Appendix, Fig. S5). These transient
“flares” of p16INK4a expression in peripheral blood occurred in
otherwise well-appearing mice and generally resolved within
1 mo of initial observation. Up to 30–40% of mononuclear blood
cells were found to be tdTom+ during these episodes, and all six
observed cases showed a sharp increase within the Mac-1+
population. We have noted similar flares of luciferase activity in
p16LUC/+ mice (23) and reasoned these episodes might represent
a transient, subclinical inflammatory state (e.g., an occult viral
infection). However, we were unable to provoke such responses
by administering p16tdTom/+ mice Toll-like receptor agonists (e.g.,
polyinosinic:polycytidylic acid or lipopolysaccharide, LPS).
These data suggest that while expression of p16INK4a mRNA is
abundant in T cells from old mice, few cells in the peripheral
blood exhibit high-level activation of the p16INK4a promoter even
in old mice; although rare, transient promoter activation occurs
in a minority of adult mice for unidentified reasons.
Next, we examined activation of the p16INK4a promoter in
nonhematopoietic tissues with aging. We focused on tissues
where prior work has suggested increased p16INK4a mRNA ex-
pression with aging (4, 14, 18, 39–41). We made single-cell
preparations of each tissue from young and old p16tdTom/+ mice
and then employed immunophenotyping and gating schemes
where appropriate to focus on specific tissue fractions of interest
(e.g., CD45− cells from cartilage or pancreatic islets, and Sca1+
CD34+ progenitors from adipose). We observed significant increases
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Fig. 3. p16INK4a-activated cultured MEFs exhibit senescence phenotypes. (A)
Growth-curve analysis of tdTom− and tdTom+ populations. Fold-increase was
calculated with respect to the cell number at day 0. (B) Quantification of EdU+
cells by immunofluorescence staining. (C) Representative image of SA-β-gal
staining. (D) Quantification of SA-β-gal+ cells in C. Throughout, error bars
represent SEM. The statistical significance of differences was assessed using

















































































PB Cartilage Islet IAT 
**
*
Fig. 4. Age-dependent increase in the frequency of p16INK4a-activated cells in
different tissues. (A–D) Representative FACS analysis of CD3+ (T cells), B220+ and
Mac-1+ (myeloid cells) populations from peripheral blood (PB) (A), cartilages (B),
fat progenitor cells (Sca1+CD34+) from IAT (C), and pancreatic islets (D). Tissues
were harvested from young (8- to 12-wk-old) and old (100- to 120-wk-old)
p16tdTom/+ mice. (E) Quantification of tdTom+ cells from the indicated tissues.
Error bars represent SEM (n = 3–4 per group). The statistical significance of dif-
ferences was assessed using unpaired two-tailed Student’s t tests (*P < 0.05).
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in the frequency of tdTom+ cells with aging in single cells derived
from articular cartilage, inguinal adipose tissue (IAT), and pan-
creatic islets (Fig. 4 B–E). The percentage of tdTom+ cells increased
∼4- to 18-fold in these tissue compartments when comparing young
and old mice, suggesting that the frequency of individual chon-
drocytes, white adipose progenitors, and β-cells having high-level
activation of the p16INK4a promoter increases with aging.
Characterization of p16INK4a-Activated Macrophages. While we were
able to identify significant numbers of p16INK4a-expressing cells
from several tissues with aging, the low frequency of tdTom+
cells (<10%) and difficulty of isolating these fractions prevented
us from further functional and molecular characterization. There-
fore, we turned to a recently described inflammatory model to
induce high-level p16INK4a expression in activated macrophages in
vivo (42). Toward that end, we implanted quiescent neonatal
dermal fibroblast (NDF)-containing alginate beads into p16LUC/+
or p16tdTom/+ mice via intraperitoneal injection. Prior work has
shown that these quiescent NDFs quickly acquire SA-β-gal staining
and release soluble factors, including IL-6 and IL-8, in turn leading
to a large influx of inflammatory cells (42). As reported, NDF
beads induced a strong luminescent signal in the abdomen of
p16LUC/+ mice by 3 wk postinjection (Fig. 5A). Flow cytometric
analysis of cells in the peritoneal lavage of p16tdTom/+ mice 3 wk
after implanting NDF beads showed a strong induction of tdTom
expression in macrophage (Mac-1+F4/80+) populations (Fig. 5B),
but not other lavage cell types (e.g., T cells, B220+ cells, and eo-
sinophils) (SI Appendix, Fig. S6). To characterize peritoneal
macrophages with high-level p16INK4a promoter activation, we
isolated Mac-1+F4/80+ cells by FACS based on tdTom expression.
Using this approach, we observed a much greater enrichment of
p16INK4a mRNA expression in tdTom+ vs. tdTom− macrophages
(40-fold) (Fig. 5C) compared with that seen in MEFs (fivefold)
(Fig. 2B). This likely reflects much greater homogeneity among
the sorted macrophages compared with mixed MEF cultures. As
was the case for MEFs, tdTom+ macrophages exhibited a marked
reduction in EdU incorporation (Fig. 5D) and increased SA-β-gal
activity (Fig. 5 E and F). It is worth noting that SA-β-gal activity
has been considered an unreliable marker of senescence in vivo,
especially in this cell type (43, 44). These results show that a sub-
stantial fraction of macrophages induced in response to NDF-loaded
beads exhibit features of senescence: activation of the p16INK4a
promoter, reduced proliferation, and expression of SA-β-gal
activity.
Prior studies suggest that p16INK4a also influences cell-intrinsic
properties of macrophages, such as M1/M2 polarization (45, 46).
To further investigate the effect of p16INK4a on macrophage func-
tion, we examined the immunophenotype and cell-specific functions
of p16INK4a-activated macrophages in more detail. We did not ob-
serve a difference in the immunophenotype of tdTom+ vs. tdTom−
lavage cells with regard to macrophage polarity (e.g., CD80, CD206,
and MHCII). Moreover, we did not find a modulation of p16INK4a
promoter activity by M1/M2 polarizing agents including LPS and
IL-4 in either tdTom+ or tdTom− macrophages (SI Appendix, Fig.
S7). However, in vitro phagocytosis assays showed that tdTom+
macrophages exhibited greater phagocytic activity than tdTom− cells
(Fig. 6 A and B). This demonstration of altered or even increased
cellular function is reminiscent of findings in other cell types in the
setting of high-level p16INK4a expression [e.g., increased insulin se-
cretion from p16INK4a-expressing pancreatic β-cells (47) and in-
creased cell killing in senescent T cells (46, 48)].
To study the underlying mechanisms and genes responsible for
the response of p16INK4a-activated macrophages to NDF-beads,
we performed RNA-seq of tdTom+ vs. tdTom− peritoneal macro-
phages. We identified 456 transcripts being up-regulated and 118
transcripts down-regulated in tdTom+ macrophages (P < 0.01).
Through GSEA, we identified several gene signatures related to
the cell cycle, senescence, and macrophage functions (Fig. 6 C–
E). Specifically, consistent with the decreased proliferation of
these cells (Fig. 5D), tdTom+ macrophages exhibited a profound
decline in the expression of transcripts associated with cell cycle
traversal and ribosomal proteins. Even though expression of a
few “cell cycle”-classified genes was increased in tdTom+ cells,
these were largely inhibitors of the cell cycle such as p16INK4a/Arf
(Cdkn2a) and p15INK4b (Cdkn2b) (Fig. 6E). Macrophages with
high-level activation of the p16INK4a promoter also exhibited
increased expression of lysosomal mRNAs, consistent with the
observed increase in β-galactosidase activity (Fig. 6 C and D). In
accord with the immunophenotypic analysis, we did not observe
differential expression of genes associated with M1/M2 macro-
phage polarization (e.g., Nos2, Arg1, and Ym1/2). On the other
hand, we found increased expression of genes involved in phago-
cytosis in tdTom+ macrophages (Fig. 6D), consistent with the
high phagocytic activity of p16INK4a-activated macrophages (Fig.
6 A and B). Additionally, we found clear up-regulation of several
components and regulators of the extracellular matrix (ECM) or
the “matrisome,” including collagens, matrix metalloproteinases,
thrombospondins, and fibulins (Fig. 6 C and E), and these
changes were highly consistent with prior studies of the ECM in
senescent cells (35, 49). Finally, using the list of SASP transcripts
developed for the MEF RNA-seq studies (SI Appendix, Fig. S4 and
Table S1), we showed a strong enrichment by GSEA for SASP
transcripts in tdTom+ cells (e.g., IL7, Mmp12, Timp2, Cxcl12/13,
Hgf), while only one SASP transcript, Mif was expressed at lower







Fig. 5. Reduced proliferation and high SA-β-gal activity of p16INK4a-acti-
vated peritoneal macrophages. (A) Bioluminescence imaging of p16LUC/+
mice following intraperitoneal injection with empty (control, CNTL) or qui-
escent human NDF-embedded alginate beads. Representative image was
acquired 21 d after bead injection. (B) Representative FACS analysis of
peritoneal macrophages (Mac-1+F4/80+) from p16+/+ (WT) and p16tdTom/+
mice at day 21 after NDF-bead injection. (C) mRNA expression of p16INK4a by
qRT-PCR in FACS-sorted tdTom− and tdTom+ peritoneal macrophages. Fold-
difference was calculated with respect to the mRNA levels in the tdTom−
fraction. (D) Quantification of EdU+ cells by immunofluorescence staining.
(E) Representative image of SA-β-gal staining. (F) Quantification of SA-β-gal
level in E. Throughout, error bars represent SEM. The statistical significance
of differences was assessed using unpaired in C and paired two-tailed Stu-
dent’s t tests (*P < 0.05, **P < 0.01) in D and F.








Contrary to less clear results generated from heterogeneous
MEFs, these studies were carried out in a well-defined in vivo
hematopoietic subtype and demonstrate that p16INK4a-activated
macrophages exhibit multiple features of senescent cells by gene
expression analysis, including decreased replication, increased
lysosomal activity, altered ECM production, and expression of
many classic SASP factors.
Discussion
Here we report a p16tdTom knockin allele that allows for the
purification and molecular characterization of individual cells in
vivo featuring high-level activation of the p16INK4a promoter.
Using this allele, we show that the p16INK4a locus is activated in
cultured MEFs with serial passage, in specific tissues with aging,
and in activated macrophages after inflammatory challenge. We
show that these p16INK4a-activated cells exhibit features of cel-
lular senescence including hyporeplication, increased expression
of SA-related matrisomal transcripts, high activity of SA-β-gal,
and expression of transcripts associated with SASP.
Prior efforts to generate a single-cell reporter of p16INK4a ex-
pression in our group have been unsuccessful due to low ex-
pression of the knocked-in reporter transcript. While other
groups have reported transgenic mice featuring a fluorochrome
reporter under the control of the p16INK4a promoter (10, 17),
very little work on the analysis of isolated p16INK4a-expressing
cells from these mice has been described, likely reflecting low level
expression of the reporter in these systems as well. In the knockin
reporter mice described herein, expression of p16INK4a is driven by
intact cis-regulatory elements of the Cdkn2a locus, to most faith-
fully recapitulate the activation of p16INK4a under physiological
conditions. To produce a more useful reporter strain, we used an
ultrabright fluorochrome (tdTom) and also left the neomycin-
selection cassette within the first intron of p16INK4a to serve as a
local enhancer of expression. This latter approach has been
reported by other groups to not adversely affect the fidelity of the
reporter transcript (25, 26), as appears to be the case with this
allele. This allele is well-suited for the detection of cells with
p16INK4a activation as we detected a high frequency of tdTom+
cells in multiple settings: in vitro (up to 60% of cells in late-
passaged MEFs), physiologic aging (>6% of cells in certain tis-
sues from old mice), as well as in peritoneal macrophages from
bead-injected mice (>10%). This approach allows for purification
by FACS and further biological and molecular characterization.
We noted the reporter strain is a more faithful measure of
p16INK4a promoter activation than transcript abundance. For
example, by performing FACS to isolate tdTom+ MEFs, we
could identify populations of nondividing cells with increasing
p16INK4a expression and decreasing tdTom expression (Fig. 2 C–
E). This observation at least in part reflects the decreased half-
life of the knocked-in transcript (tdTom, ∼12 h) compared with
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Fig. 6. Gene-expression profile of p16INK4a-activated peritoneal macrophages. (A) In vitro phagocytosis of pHrodo Green Zymosan bioparticles in peritoneal
macrophages. Representative FACS analysis of tdTom− and tdTom+ macrophages. (B) Quantification of phagocytosed macrophages. Error bars represent SEM.
The statistical significance of differences was assessed using paired two-tailed Student’s t tests (*P < 0.05). (C and D) GSEA of tdTom− vs. tdTom+ peritoneal
macrophages. Representative plots for significantly enriched gene sets at false-discovery rate < 0.01 are shown with their respective normalized enrichment
score. (E) Heatmap of differentially expressed genes in tdTom− vs. tdTom+ populations. FACS sorted tdTom− samples (Left, black bar), and tdTom+ samples
(Right, red bar). Representative genes in each gene set are listed to the right of the heatmap. The log2 ratio to the mean value of each gene is indicated by the
color scale. GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes.
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the endogenous p16INK4a transcript (>24 h). Of note, the discovery
of the extraordinary stability of the p16INK4a and Arf dates to the
mid-1990s (31), but the structural basis for this finding is still
unknown. While it is believed that the p16INK4a promoter is per-
sistently active in senescent cells, the kinetics of promoter acti-
vation in individual senescent cells has not been studied. These
findings suggest that activation of the p16INK4a promoter in newly
senescing cells might peak at the time of cell cycle arrest, and then
in some cases, decrease to a state of lower engagement. Because
the tdTom allele does not label such p16INK4a-expressing cells with
low promoter activity, we are confident this allele does not detect
all senescent cells in vivo. We believe this observation is relevant
to other systems using the p16INK4a promoter to label senescent
cells in aging or stressed animals. For example, it is possible the
benefits observed in aged mice relying on p16INK4a promoter ac-
tivation to deplete senescent cells in vivo (17, 18) represent an
underestimate of the effects of complete organismal senolysis.
The estimates of increased p16INK4a expression with aging differ
using this allele as opposed to other methods. For example, whereas
increased mRNA expression is readily detected in pooled murine
T cells with aging, we noted little increase in tdTom+ T cells with
aging. Similarly, using antibody-based approaches, others have
suggested very high levels of p16INK4a-expressing pancreatic β-cells
with aging (50), whereas we only observed evidence of high-level
promoter activation in ∼3% of pancreatic islet cells from old mice
(Fig. 4E). This could reflect technical differences (e.g., the sensitivity
of qRT-PCR and immunohistochemistry compared with flow
analysis), but we believe a more likely explanation relates to the
function of the p16tdTom reporter allele. Specifically, we believe this
discordance is further evidence that most senescent cells show high
levels of p16INK4a mRNA abundance, but not necessarily high-level
p16INK4a promoter activation. Presumably, these cells are able to
accumulate high levels of the p16INK4a transcript despite modest
promoter activity because of the marked stability of the endogenous
p16INK4a transcript.
The role of p16INK4a in macrophage biology is an area of
emerging interest. Sherr and coworkers (51) demonstrated that
macrophages can express high levels of p16INK4a under some set-
tings, and this induction causes a potent growth arrest in this cell
type. Motivated by human genome-wide association studies link-
ing the CDKN2a/b locus to atherosclerotic disease, we previously
showed reduced INK4a/ARF expression in humans harboring risk
alleles for atherosclerosis (52), a model supported by murine
studies suggesting Ink4a/Arf expression in macrophages prevents
atherosclerosis (53). It is unclear, however, how p16INK4a expres-
sion in macrophages would prevent atherosclerosis. It is possible
p16INK4a expression limits the proliferation of macrophages or its
progenitors and thereby reduces macrophage number in a nascent
atherosclerotic plaque. The recent observation from Van Deursen
and coworkers (54) showed that p16INK4a-expressing macrophages
themselves do not protect from atherosclerosis, as the elimination
of these cells actually reduced plaque size. The complex role of
p16INK4a expression in macrophage function may be related to
observations that p16INK4a plays a role in altering macrophage
function, such as the regulation of M1/M2 polarization (45, 46).
Some debate exists as to whether macrophages expressing high
levels of p16INK4a should be considered “senescent.” In fact, there
are currently no universal and completely reliable markers to
identify senescent cells in vivo due to the heterogeneity of senes-
cence phenotypes in living animals (6). Gudkov and coworkers (44)
have argued that SA-β-gal and p16INK4a expression in vivo are not
pathognomonic for senescence [a view we share (6)] and have
shown in analyses of pooled cells that p16INK4a activation can be
reversible by immunomodulatory agents. In accord with that prior
work (42), we noted that NDF-loaded beads potently induced an
influx of macrophages featuring strong p16INK4a activation 2–3 wk
after implantation. We also found these p16INK4a-activated mac-
rophages have SA-β-gal activity and exhibit increased phagocytic
ability. Using FACS-sorting to limit our analysis to p16INK4a-acti-
vated cells, we noted both functional and transcriptional features of
this population that have been linked to senescence: hyporeplication,
altered ECM production, and expression of proinflammatory
cytokines. We did not observe a difference between cells with
low and high p16INK4a promoter activity with regard to mac-
rophage polarity, nor did we find a modulation of p16INK4a
promoter activity by M1/M2 polarizing agents in these two fractions.
These results suggest that previous findings on macrophage
polarization may represent differences in terms of the specific
population of cells studied, and differences in the reporter
systems employed. While macrophages having high-level acti-
vation of the p16INK4a promoter displayed features of senes-
cence in this study, an unambiguous claim that these cells are
senescent is challenging given the physiological response of mac-
rophages to environmental stresses. Macrophages show altered
proliferation (55–57) and secretion of either pro- or antiin-
flammatory cytokines to promote immune response and ECM
remodeling (58–60) in response to environmental cues. Regardless
of the classification of these cells, the notion suggested by Gudkov
and coworkers (42, 44) that such cells accumulate in response to
tissue senescence and contribute to age-associated pathology re-
mains highly intriguing and is supported by this work.
In summary, this study shows that some p16INK4a-activated
cells in vivo exhibit multiple characteristics of cellular senes-
cence, and these cells accumulate with aging in several tissues.
Our findings suggest a three-component definition of senescent
cells in vivo: high-level p16INK4a activation, reduced replication,
and expression of senescence-associated transcripts (e.g., SASP
and ECM). These data also identify an unexpected relationship
between promoter activation and transcript abundance, with
implications for the use of p16INK4a as an in vivo marker of se-
nescence. Finally, this allele allows for the isolation and char-
acterization of individual cells that are produced by the process
of normal aging, feature high-level p16INK4a promoter activation,
and contribute to varied, age-associated pathologies.
Methods
Animals. Animals were housed in an Association for Assessment and Ac-
creditation of Laboratory Animal Care-accredited facility and treated in ac-
cordance with protocols approved by the Institutional Animal Care and Use
Committee for animal research at the University of North Carolina.
Generation of the p16tdTom Allele. This allele was generated via standard
homologous recombination procedures in hybrid C57BL6/129SvEv embryonic
stem cells. Germline transmission was confirmed, and the allele was back-
crossed seven generations to C57BL/6 before further analysis. Animals were
studied with and without FlpE-mediated excision of the neomycin selection
cassette, as described in Results. The primers and PCR conditions used for
p16tdTom genotyping were as following: p16-tdTom 5′-AAGCCCTCGGG-
GAAGGACAG-3′ (0.15 mM); p16-F 5′-GGAAGGAAGGAGGGACCCACTG-3′
(0.15 mM); p16-R 5′-AGAGTTCGGGGCGTTGGGC-3′ (0.15 mM); 95 °C for
1 min, 34× (95 °C for 15 s, 65 °C for 15 s and 72 °C for 30 s), 72 °C for 10 min.
The resulting PCR products are 204 (WT) and 352 (p16tdTom) base pairs long.
Isolation and Culture of MEFs. MEFs were generated and cultured as pre-
viously described (23).
Quantitative Reverse-Transcriptase PCR. Total RNA and cDNA were prepared
from serially passaged MEFs and sorted samples using the RNeasy Mini Kit
(Qiagen) and ImPro-II reverse transcriptase (Promega) according to the
manufacturer’s instructions. The qRT-PCR strategy for the detection of
p16INK4A was previously described (6). The primers and probe used for the
detection of tdTomato were as following: tdTom-F 5′-ACCTCCCACAACGA-
GGACTA-3′; tdTom-R 5′-CTTGTACAGCTCGTCCATGC-3′; Probe 5′- [FAM] CC-
GCCACCACCTGTTCCTGT [TAM]-3′. For absolute quantification of transcript
abundance, fragments of p16INK4a and tdTomato were cloned, and a standard
curve was generated using serial dilution.








Single-Cell Quantitative Reverse-Transcriptase PCR. Single tdTom+ MEFs were
sorted into a 96-well plate containing cell lysis buffer. Reverse transcription
and preamplification of genes of interest were performed using the Single-
Cell-to-CT Kit (Invitrogen) according to the manufacturer’s guidelines, fol-
lowed qRT-PCR analysis, as described above.
Tissue Dissociation and Flow Cytometry Analysis. Blood samples were treated
with ACK (ammonium-chloride-potassium) lysis buffer to remove red blood
cells before the staining of select markers. Cartilage tissue was dissected from
the proximal end of the femur (hip) and the end of the tibial plateau (knee),
followed by predigestion with 2 mg/mL pronase (EMD Millipore) in serum-
free media for 1 h at 37 °C and then digestion overnight with 0.4 mg/mL
Collagenase P (Roche Diagnostics) in 10% serum media. Pancreatic islets
were isolated as previously described (31) and dissociated into a single-cell
suspension by 0.05% trypsin-EDTA for 3 min at 37 °C. Single cells from car-
tilages and islets were stained with CD45 (30-F11). Single cells derived from
IAT were prepared and stained as previously described (13, 28). Cells were
stained with the antibodies in HBSS with 2% FBS and analyzed in HBSS with
2% FBS and 2 mg/mL DAPI using LSRII (BD) flow cytometers. FACS data were
analyzed using FlowJo software (TreeStar).
Alginate Bead Experiment. Empty and NDF-embedded alginate beads were
prepared as described previously (30). Beads were implanted into mice via
intraperitoneal injection, and peritoneal lavage was collected at day 21–
30 postinjection. For analysis by flow cytometry, peritoneal cells were washed
with HBSS plus 2% heat-inactivated FBS and blocked with anti-CD16/CD32
(clone 93) for 10 min on ice, followed by staining with anti-F4/80 (BM8), anti–
Mac-1 (M1/70), CD170 (1RNM44N), and following Biotin conjugated anti-
bodies: anti-CD3 (145-2C11), anti-CD19 (6D5), anti-B220 (RA3-6B2), anti-Ter119
(TER-119), and anti-NK1.1 (PK136) for 30 min on ice. Cells were then washed
and stained with fluorophore-conjugated streptavidin for 20 min on ice,
followed by one wash, and resuspended with HBSS plus 2% heat-inactivated
FBS and 2 mg/mL DAPI.
In Vivo Bioluminescent Imaging. Isoflurane-anesthetized mice were injected
intraperitoneally with D-luciferin potassium salt (15 mg/mL in PBS; PerkinElmer)
and imaged using IVIS Lumina (Caliper Life Sciences). Sequential imaging was
performed upon injection, 2 min in length, and 8 min in total.
In Vitro and in Vivo Cell Sorting. Serial-passaged MEFs or bead-induced
peritoneal macrophages were sorted by FACS into tdTom− and tdTom+ pop-
ulations using MoFlo XDP (Beckman Coulter) or FACSAria III (Becton Dickinson).
Sorted cells were used for the functional studies described below and the RNA-
seq experiment.
In Vitro Cell Growth Assay. For the in vitro cell growth assay, 5 × 104 sorted
MEFs were seeded and cultured for 5 d. Total cell number was measured at
days 1, 3, and 5.
In Vitro and in Vivo EdU Incorporation. Sorted MEFs were pulsed with 5 μg/mL
EdU for 2 h in a CO2 incubator at day 1 postsort, followed by fixation in 3.7%
paraformaldehyde for 10 min and permeabilization in PBS plus 0.5% Triton X-
100 for 15 min at room temperature. EdU staining was performed in 0.1 M
Tris·HCl (pH 7.5), 1 mM CuSO4, 0.1 M ascorbic acid, and 1 μM AlexaFluor
555 azide (Life Technologies) for 30 min at room temperature. Stained cells
were washed twice with PBS plus 0.5% Triton X-100 and then incubated with
2 mg/mL DAPI for 5 min before immunofluorescence microscopy analysis. For
in vivo analyses, mice were treated with 10 mg/kg EdU via intraperitoneal
injection every 12 h, five injections in total. EdU-labeled peritoneal macro-
phages were stained as described above.
In Vitro Phagocytosis Assay. For in vitro phagocytosis assay, 1 × 106 peritoneal
cavity cells harvested frommice were incubated with 0.2 mg/mL pHrodo Green
Zymosan Bioparticles (Thermo Fisher Scientific) for 60 min at 37 °C. Treated
cells were washed and stained for macrophage markers as described above.
In Vitro Treatment. For in vitro treatment, 1–2 × 105 FACS-sorted tdTom− and
tdTom+ peritoneal macrophages or 1 × 106 peritoneal cavity cells harvested
from NDF bead-elicited mice were plated overnight in an uncoated 12-well
plate, followed by ≤72 h treatments of LPS (Sigma) or IL-4 (Biolegend).
Treated cells were analyzed by flow cytometry as described above.
SA-β-Gal Staining. FACS-sorted samples were stained for SA-β-gal activity at
day 1 postsort using Cellular Senescence Assay Kit (Millipore) according to
the manufacturer’s protocol. Positive staining was quantified by ImageJ and
Image Pro Premier software.
mRNA Stability Assay. p16tdTom/+ MEFs were treated with 5 μg/mL ActD. Cells
were then harvested at time 0, 2, 6, 12, and 24 h posttreatment, and RNA
was purified, followed by qRT-PCR.
RNA Sequencing and Analysis. Total RNA was isolated from sorted tdTom− and
tdTom+ MEFs and peritoneal macrophages using TRIzol LS reagent (Thermo-
Fisher) according to the manufacturer’s instructions, followed by the clean-up
using NucleoSpin RNA XS (Clontech). RNA-seq libraries were constructed with
the TruSeq RNA kit v2 (Illumina) and validated using the Agilent 2200
TapeStation system. The 150-cycle paired-end sequencing runs were gener-
ated with an Illumina NextSeq500 at the University of North Carolina Trans-
lational Genomics Laboratory. Purity filtered reads were aligned to the mouse
reference genome (mm9) using STAR. Transcript abundance for each sample
was estimated by Salmon (32). Differential expression between tdTom− and
tdTom+ samples was computed using DESeq2 (33).
GSEA. GSEA was performed as previously described (34). Enrichment of dif-
ferentially expressed genes in tdTom− vs. tdTom+ cells was carried out
against preranked gene lists. Default parameters were used.
Statistical Analysis. To determine the correlation of two sample groups, linear
regressionwas performed. Statistical comparison of two groups was performed
using a two-tailed unpaired Student’s t test. For statistical comparisons of
paired groups (e.g., sorted tdTom− vs. tdTom+), a two-tailed paired Student’s
t test was performed. Differences were considered statistically significant at P
values less than 0.05: *P < 0.05, **P < 0.01. All data presented as mean ± SEM.
Sample sizes for all data are indicated in each figure legend.
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